https://www.nycfacedoc.com/assets/condition__chronic-sinusitis-C5XVWM2W.js

1const e="condition",i="chronic-sinusitis",a="/assets/heroes/sinus-default.webp",n="https://nycfacedoc.com/conditions/chronic-sinusitis/",s="Chronic Sinusitis Treatment NYC — Evaluation & Surgery | Dr. Mourad",t="Chronic Rhinosinusitis: Diagnosis and Treatment in Manhattan",o="Dr. Moustafa Mourad evaluates chronic rhinosinusitis in Manhattan with nasal endoscopy, CT review, and individualized medical or surgical plans. Request a consultation.",r="https://www.nycfacedoc.com/conditions/chronic-sinusitis/",c="Chronic Rhinosinusitis",l={title:"Chronic Sinusitis Treatment NYC — Evaluation & Surgery | Dr. Mourad",description:"An anatomy-first evaluation of chronic rhinosinusitis in Manhattan: nasal endoscopy, CT review, and tailored medical or surgical options with Dr. Mourad.",url:"https://www.nycfacedoc.com/conditions/chronic-sinusitis/",image:"/og/chronic-sinusitis.jpg"},d={title:"Chronic Sinusitis Treatment NYC — Dr. Mourad",description:"Nasal endoscopy and CT-driven plans for chronic rhinosinusitis in Manhattan, with medical and surgical options tailored to anatomy and inflammation."},p="Dr. Moustafa Mourad is board-certified by the American Board of Facial Plastic and Reconstructive Surgery (ABFPRS) and the American Board of Otolaryngology — Head and Neck Surgery (ABOto), and serves as an AAFPRS fellowship director in New York City. He frames chronic rhinosinusitis as an anatomic and inflammatory disorder in which ostial patency, mucosal health, and topical drug delivery determine symptom persistence. Definitive decisions about medical versus surgical therapy are made only after an in‑person nasal endoscopy and CT review in clinic.",u=JSON.parse('[{"heading":"What the condition is","paragraphs":["Chronic rhinosinusitis is a persistent inflammatory disorder of the nasal mucosa and paranasal sinuses that lasts twelve weeks or longer. Clinically, it differs from an acute sinus infection by duration and by the tendency toward ongoing mucosal inflammation rather than a single infectious episode. The term captures several biological patterns: polyp-predominant disease (nasal polyps are edematous mucosal growths), nonpolypoidal disease, and mixed presentations. Each pattern implies a different balance of obstruction, immune activity, and mucociliary dysfunction. Describing the dominant pattern early guides whether the immediate focus should be medical control of inflammation or addressing an anatomic barrier to drainage and topical therapy.","In practice, chronic rhinosinusitis is a syndrome rather than a single diagnosis. Symptoms reflect interplay among mucosal swelling, impaired mucociliary clearance (the cilia-driven transport of mucus), and ventilation defects caused by ostial narrowing. When the sinus ostia—the small drainage openings of each sinus—remain narrowed, secretions and inflammatory mediators accumulate. That stagnant environment predisposes to persistent bacterial colonization and formation of biofilms, which further perpetuate inflammation. Recognizing chronic disease as a self-sustaining process clarifies why repeated short antibiotic courses alone are rarely sufficient for durable control.","A pragmatic clinical distinction involves presence or absence of nasal polyps, because polyps often indicate an eosinophil-predominant inflammatory endotype. Eosinophilic disease tends to respond well to corticosteroids yet shows higher recurrence without longer-term anti-inflammatory strategies. Nonpolypoidal disease more commonly reflects focal anatomic problems or neutrophil-dominant inflammation. The distinction matters for sequencing treatment: topical corticosteroids, saline irrigations, and biologic therapies target inflammation, while endoscopic sinus surgery or balloon dilation target anatomy and topical delivery pathways.","Chronic rhinosinusitis carries variable symptom patterns and functional impact, from bothersome congestion to marked smell loss and sleep disturbance. The diagnosis relies on symptom duration and objective findings, not symptoms alone. Nasal endoscopy and sinus CT provide the anatomic and mucosal detail necessary to avoid misclassification. In all cases, clinical judgment integrates symptom history, prior response to therapy, and comorbidities before recommending prolonged medical therapy or a procedural approach. Surgical candidacy and specific operative plans are decided only after in-person asse

1ssment, endoscopy, and CT review."]},{"heading":"Relevant anatomy","paragraphs":["Anatomic detail explains why chronic problems localize and recur. The four paired paranasal sinuses—maxillary, frontal, ethmoid, and sphenoid—drain through narrow ostia into the nasal cavity. The ostiomeatal complex, a tightly configured region of the lateral nasal wall, commonly serves as a choke point for the anterior sinuses. Narrowing at that site produces impaired ventilation and mucus stasis across multiple sinuses. When surgery is considered, the goal is to re-establish physiologic drainage pathways while preserving healthy mucosa and mucociliary function.","Turbinates and the nasal septum shape airflow and topical medication delivery. The inferior turbinates sit along the lateral nasal wall and may hypertrophy (enlarge) with chronic inflammation, causing persistent obstruction. Septal deviation can redirect airflow away from sinus ostia, reducing irrigation and spray penetration. Procedures such as septoplasty surgery for a deviated septum — /septoplasty-surgery-nyc/ and turbinate reduction to improve nasal airflow — /turbinate-reduction/ are often considered when structural factors prevent adequate topical therapy or impair breathing.","The olfactory cleft and superior nasal vault deserve separate attention because they relate directly to smell loss. Inflammation, polyps, or scarring in these superior regions frequently cause anosmia or hyposmia. The mucociliary apparatus—ciliated epithelial cells that move mucus toward the nasopharynx—provides innate clearance. Longstanding infection, smoking, or certain systemic diseases can damage cilia and slow recovery. Surgical planning tries to restore drainage and topical access without unnecessary disruption of olfactory mucosa or ciliated surfaces.","Anatomic variants change both disease patterns and operative risk. Concha bullosa (an aerated middle turbinate), Haller cells (infraorbital ethmoid air cells), and frontal recess variations alter frontal sinus access and the likelihood of persistent disease. High-resolution sinus CT maps these variants and informs whether a targeted balloon dilation of an ostium or a formal functional endoscopic sinus surgery (FESS) is necessary. Accurate anatomic mapping improves the precision of any intervention and reduces the need for revision procedures."]},{"heading":"Common symptoms","paragraphs":["Patients with chronic rhinosinusitis typically report combinations of nasal obstruction, nasal discharge, facial pressure, and reduced sense of smell. Nasal obstruction feels like persistent congestion rather than intermittent seasonal stuffiness. Discharge may be anterior or posteriorly dripping and vary from clear to mucoid or purulent. Facial pressure often presents as fullness or aching localized to the affected sinus region. Olfactory disturbance (reduced smell) is functionally significant and can appear early in polyp-predominant disease because polyps commonly occupy the olfactory cleft.","Distinguishing chronic sinus symptoms from allergic rhinitis, migraine, or dental pain depends on associated features and timing. Allergic rhinitis often includes sneezing, itchy eyes, and seasonal triggers. Migraines produce unilateral, pulsatile head pain with photophobia and nausea rather than persistent nasal discharge. Odontogenic pain localizes to upper teeth and sometimes simulates maxillary sinus discomfort; dental imaging or referral helps separate these causes. A careful history of symptom triggers and response to prior therapies clarifies the likely source and prevents misdirected treatments.","Certain symptom clusters point toward specific subtypes. Bilateral obstruction with profound smell loss suggests polyp disease or marked eosinophilic inflammation. Focal, recurrent purulent drainage or unilateral symptoms raise concern for anatomic obstruction, previous trauma, or an odontogenic origin. Severe fever and rapidly progressive facial swelling are uncommon in chronic rhinosinusitis and should prompt urgent assessment for acute complication. Duration and failure of prior appropriate medical therapy help determine the need for endoscopy and CT to guide further care.","Chronic cough, throat clearing, and sleep disturbance are common adjunctive complaints when sinonasal disease persists. When asthma coexists, sinonasal inflammation often worsens lower airway symptoms and vice versa. Identifying these overlaps alters management priorities and encourages coordinated care with pulmonology or allergy specialists when indicated. Documenting symptom severity and functional impact guides the decision to escalate to procedural interventions versus continued medical optimization."]},{"heading":"Common causes and risk factors","paragraphs":["Multiple mechanisms sustain chronic sinonasal inflammation. Allergic sensitization promotes mucosal swelling and impaired drainage through IgE-mediated pathways. Asthma frequently coexists and shares inflammatory biology with the upper airway. Structural factors—septal deviation, turbinate hypertrophy, or ostial narrowing—create focal stasis where mucus and inflammatory cells accumulate. Smoking, environmental irritants, and prior infections further damage mucociliary clearance and impede recovery. A comprehensive history identifies these contributors and separates modifiable from intrinsic risk factors.","Eosinophilic inflammation and nasal polyps reflect a distinct endotype that often responds to systemic and topical corticosteroids but frequently recurs. When polyp burden is high, consideration of biologic therapy may be appropriate in addition to surgical strategies. Current randomized trial evidence supports use of dupilumab for steroid-refractory polyp disease; see clinical trial summaries for dupilumab in nasal polyps (clinical evidence). For management algorithms, consult the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) guidance and AAO‑HNS statements on adult sinusitis for up-to-date recommendations (see links below).","Bacterial biofilms and chronic colonization complicate eradication because biofilms protect organisms from antibiotics and host defenses. When biofilms are suspected, culture-directed topical or systemic therapy combined with improved sinus ventilation can increase the likelihood of control. Primary ciliary dyskinesia and cystic fibrosis are distinct pediatric and young-adult contributors that require separate diagnostic pathways and specialized multidisciplinary care. Identifying these conditions early changes prognosis and prioritizes medical over purely anatomic approaches.","Medication effects and comorbidities also sustain symptoms. Overuse of topical sympathomimetic decongestants causes rebound congestion, and some systemic medications produce nasal dryness or swelling. Gastroesophageal reflux and sleep-disordered breathing may aggravate throat symptoms and cough. Recognizing and addressing these factors—tobacco cessation, stopping offending sprays, or coordinating care with gastroenterology—supports durable improvement and reduces the likelihood of recurrent interventions."]},{"heading":"Why accurate diagnosis matters","paragraphs":["An accurate diagnosis identifies the dominant drivers of disease and prevents ineffective treatments. Knowing whether obstruction, eosinophilic inflammation, infection, or a mixed process predominates determines initial therapy. For example, endoscopic sinus surgery restores ostial patency and topical delivery but does not replace systemic control of an underlying eosinophilic disorder. Conversely, biologic agents reduce polyp burden and systemic inflammation but do not repair a mechanical septal deviation. Matching mechanism to treatment improves symptom control and reduces unnecessary procedures.","Objective testing—nasal endoscopy and sinus CT—provides the anatomical and mucosal detail necessary to choose between medical and surgical pathways. Endoscopy permits direct visualization of polyps, purulence, crusting, and lateral wall anatomy. CT imaging clarifies frontal recess anatomy, Haller cells, and ostial obstruction patterns. These tests appear in international guidelines such as the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) and AAO‑HNS adult sinusitis guidance, which recommend objective assessment before definitive surgical decisions (EPOS 2020; AAO‑HNS).","Accurate subtyping also guides perioperative planning and risk mitigation. Recognizing eosinophilic disease, prior extensive surgery, or concomitant asthma influences intraoperative technique, postoperative topical regimens, and the likelihood of adjunctive immunomodulatory therapy. Culture-directed therapy and targeted allergy evaluation reduce recurrence when infection or allergic sensitization contribute. Systematic reviews comparing balloon dilation and FESS inform selection of less invasive options for selected ostial disease patterns; see Cochrane and randomized trial summaries for comparative outcomes.","Finally, accurate diagnosis protects patient safety and sets realistic expectations. It reduces the risk of unnecessary procedures in patients with primarily allergic disease and identifies those who need multidisciplinary care for conditions such as cystic fibrosis or primary ciliary dyskinesia. Objective correlation between symptoms, endoscopy, and CT reduces diagnostic uncertainty and enables a shared decision-making conversation about risks, benef

1its, and likely timelines for symptom change after medical or surgical therapy."]},{"heading":"How Dr. Mourad evaluates this condition","paragraphs":["Dr. Moustafa Mourad begins with a focused history that probes symptom chronology, prior treatments, and comorbid conditions. He asks about prior steroid response, frequency and duration of antibiotic courses, previous sinus operations, asthma, and allergic triggers. Occupational exposures, tobacco use, and sleep disturbances are documented because they influence mucosal health and healing. This structured history frames whether to prioritize further medical optimization, objective testing, or earlier procedural referral. Surgical candidacy and specific operative plans are determined only after an in-person assessment, endoscopy, and CT review.","Office evaluation uses nasal endoscopy (a slim, illuminated scope) to inspect the nasal cavity, middle meatus, olfactory cleft, and nasopharynx. Endoscopy documents polyps, purulent drainage, crusting, and anatomic narrowing in real time. When available, prior endoscopic images and operative reports are reviewed to understand previous interventions. Dr. Mourad integrates endoscopic findings with patient-reported symptom burden and prior response to therapy to create a personalized treatment pathway. Endoscopy also allows targeted cultures when infection is suspected and helps plan the precise surgical footprint if needed.","Sinus CT imaging is obtained or reviewed to map anatomic drivers and operative landmarks. The CT defines which sinuses are obstructed, frontal recess anatomy, and anatomic variants such as Haller cells or concha bullosa. When indicated, Dr. Mourad coordinates with allergy and pulmonology colleagues for allergy testing, culture-directed therapy, or combined management of comorbid asthma. For evidence-based guidance on testing and indications, see EPOS and AAO‑HNS resources linked here. Internal procedural options discussed include endoscopic sinus surgery (FESS) in NYC — /sinus-infections-sinus-surgery/ and balloon sinuplasty in NYC — /balloon-sinuplasty-nyc/ for select ostial disease.","Who is NOT a candidate: absolute and relative contraindications are identified explicitly. Absolute contraindications include active, uncontrolled systemic infection and situations where general anesthesia is unsafe, such as severe unstable cardiac or pulmonary disease. Relative contraindications include pregnancy timing considerations, inability to adhere to postoperative care and irrigations, uncontrolled bleeding disorders, and certain systemic conditions such as untreated cystic fibrosis or primary ciliary dyskinesia where medical therapy and multidisciplinary management should precede surgery. When a contraindication is present, Dr. Mourad discusses alternative strategies, optimization plans, or appropriate referrals.","Practical visit preparation and a postoperative roadmap improve the patient experience. Patients should bring prior sinus CT DICOM files if available, operative reports, a current medication list, and any allergy or pulmonary test results. Uploading images before the visit speeds planning. If surgery proceeds, Dr. Mourad outlines a calendar-specific recovery plan: Days 0–7 (nasal packing uncommon; expect crusting, mild bleeding, saline rinses twice daily, activity restriction, and a warning sign list); Weeks 1–3 (first debridement at 7–14 days, regular saline irrigations, topical steroid sprays begin or continue, return-to-office work at 1–2 weeks if sedentary); Weeks 4–6 (reduced crusting, gradual increase in activity, continued topical therapy, symptom re-evaluation); Months 2–3 (most swelling subsides, smell may slowly improve but remains variable); 6+ months (maturation of healing and long-term topical strategy). Warning signs at any point—fever, severe facial pain, worsening vision, or heavy persistent bleeding—require immediate evaluation. For discussion of risks and expected complication frequencies, see AAO‑HNS and EPOS guidance linked below."]},{"heading":"Non-surgical management","paragraphs":["Medical therapy forms the foundation of care for chronic rhinosinusitis (inflammation lasting twelve weeks or more). First-line measures reduce mucosal inflammation and optimize mucociliary clearance (the nose’s natural mucus-trans

1port system). High-volume saline irrigations mechanically clear secretions and reach the sinus ostia (the sinus openings) more reliably than low-volume sprays. Intranasal corticosteroid sprays or steroid irrigations reduce local inflammation. Short systemic steroid courses may help define an inflammatory phenotype when nasal polyps are suspected, but they carry systemic risks and are not a sustainable long-term strategy. Treatment decisions follow a measured in-clinic assessment including nasal endoscopy (a brief office endoscope exam) and CT review when indicated.","Antibiotics are appropriate when there is clinical or culture evidence of bacterial infection. Routine, prolonged empiric antibiotics risk resistance and often fail if anatomic blockage or underlying inflammation persist. When purulent drainage or acute exacerbation continues despite topical therapy, culture-directed therapy obtained under endoscopic guidance clarifies the responsible organisms and guides targeted antibiotic selection. Culture sampling helps avoid unnecessary broad-spectrum exposure and informs whether surgery should be considered to restore drainage. National guidelines outline conservative antibiotic use in chronic disease; see the AAO‑HNS and EPOS guidance linked below for details (AAO‑HNS; EPOS 2020).","Biologic agents are an advancing option for selected patients, primarily those with severe eosinophilic nasal polyposis or steroid-dependent disease. These medications target immune pathways driving eosinophil-rich inflammation and may reduce polyp burden and steroid requirements. Biologics do not correct fixed anatomic obstruction that prevents topical medication delivery, so selection requires coordinated evaluation with allergy or immunology. Decisions about escalating to biologic therapy versus proceeding to procedural correction rest on endoscopic findings, CT anatomy, and prior treatment response. Key trial data support biologic use in specific populations; see the dupilumab trial in NEJM for an example of evidence in nasal polyposis.","Adjunctive measures and comorbidity management materially affect outcomes. Smoking cessation, treatment of allergic triggers, optimization of concurrent asthma or reflux, and targeted allergy testing when indicated all support durable control. Nasal saline irrigation technique and proper topical delivery matter; consider high-volume rinses or device-assisted steroid irrigations when anatomy allows. Regular clinic reassessment with nasal endoscopy provides objective information on mucosal response and helps determine whether continued medical therapy, biologic therapy, or procedural intervention is the next step. All surgical planning requires an in-person exam and imaging review before finalizing recommendations."]},{"heading":"Surgical / procedural options","paragraphs":["Who is NOT a candidate: Absolute and relative contraindications are important to recognize. Absolute contraindications include uncontrolled acute infection requiring urgent medical management and lack of anesthesia fitness for elective procedures. Pregnancy timing considerations usually defer elective sinus surgery until after delivery unless a true emergency exists. Relative contraindications include severe uncontrolled cardiac or pulmonary disease that raises perioperative risk, inability to adhere to postoperative care and follow-up, and certain primary mucociliary disorders (for example, cystic fibrosis or primary ciliary dyskinesia) where medical therapy and multidisciplinary management are often prioritized or where different surgical strategies apply. When contraindications are present, we triage patients to medical optimization, specialist collaboration, or deferment rather than immediate surgery.","Functional endoscopic sinus surgery (FESS) is an anatomy-directed, tissue-preserving operation that reopens obstructed sinus ostia and restores mucociliary function. Under endoscopic visualization, diseased tissue is removed selectively and natural drainage pathways are enlarged to improve ventilation and topical drug delivery. Extent of FESS depends on CT patterns and endoscopic findings; the procedure is individualized to target obstructive segments while preserving healthy mucosa. FESS is often preferred when disease involves multiple sinuses or when polyps and mucosal disease obstruct access. Surgical goals emphasize functional restoration rather than radical tissue removal and rely on postoperative topical therapies to maintain benefit.","Balloon sinuplasty dilates sinus ostia using a catheter-mounted balloon and can be appropriate for focal ostial obstruction of the maxillary, frontal, or sphenoid sinuses in selected patients. The technique limits mucosal disruption and may shorten recovery for well-selected anatomy and disease limited to ostial narrowing. Balloon dilation has limitations: it is not intended for diffuse polyp disease, extensive mucosal disease, or cases requiring tissue debulking. Randomized trials and systematic reviews compare balloon dilation and FESS for selected indications; review of that evidence helps match the technique to an individual sinus pattern and prior surg

1ical history (see Cochrane review link below).","Concurrent procedures commonly improve outcomes by addressing structural contributors. Septoplasty corrects a deviated septum that impairs access or perpetuates lateralized airflow. Turbinate reduction treats persistent turbinate hypertrophy that limits airflow and topical penetration. Endoscopic polypectomy removes obstructive polyp burden to reestablish ostial patency. Combining these procedures with FESS or balloon sinuplasty often enhances topical drug reach and symptomatic relief. Surgical planning accounts for reconstructive principles in revision cases, anticipates scarring, and aims to preserve mucosa where possible to reduce restenosis risk and support effective postoperative care."]},{"heading":"Risks of leaving the condition untreated","paragraphs":["Chronic sinonasal inflammation and persistent ostial obstruction create progressive symptoms that impair sleep, cognition, and daily function. Prolonged mucosal disease and polyp burden can cause sustained hyposmia (reduced smell) or anosmia (loss of smell); smell recovery becomes less likely the longer severe disease persists. Early assessment and targeted treatment increase the chance of stabilizing or partially recovering olfaction, but no surgery can promise complete restoration. Left untreated, chronic symptoms often become entrenched and more difficult to control with topical therapies alone, which may ultimately require more extensive intervention.","Anatomic sequelae of untreated obstruction include mucoceles (mucus-filled cystic expansions) and localized bony erosion when sinus outflow is blocked over time. These complications may require more extensive surgical exposure or reconstruction than earlier, targeted intervention. Recurrent acute bacterial exacerbations are common and frequently prompt repeated antibiotic courses. Repeated antibiotic exposure increases risks of adverse effects and antimicrobial resistance; culture-directed therapy and consideration of anatomic correction reduce unnecessary antibiotic cycles and downstream complications.","Although uncommon, untreated disease can spread beyond the sinonasal cavity and cause orbital or intracranial complications. Orbital spread may present as periorbital swelling, proptosis, or vision changes and requires urgent imaging and specialist care. Intracranial extension such as meningitis or abscess is rare but serious; symptoms like severe headache, neck stiffness, focal neurologic deficits, or altered consciousness demand immediate emergency assessment. Timely specialty evaluation, appropriate imaging, and early drainage or surgical intervention when indicated reduce the risk of permanent sequelae.","Chronic sinonasal inflammation interacts with lower airway disease and systemic health. Patients with coexisting asthma often experience worse respiratory control when sinonasal disease remains active. Coordinated care with pulmonology and allergy specialists reduces exacerbation risk and supports unified management of upper and lower airway disease. In short, untreated chronic rhinosinusitis is not benign; it can progress to anatomical complications, worsen comorbid respiratory disease, and diminish quality of life, all of which inform timing and urgency of specialist evaluation."]},{"heading":"When to seek care","paragraphs":["Seek specialist evaluation when symptoms persist beyond twelve weeks despite consistent, guideline-directed medical therapy. Ongoing purulent drainage, persistent nasal obstruction, sleep disruption, facial pressure that limits daily activities, or progressive smell loss warrant otolaryngology assessment. An appointment with nasal endoscopy (office endoscope exam) and CT review clarifies whether continued medical management, allergy testing, or procedural intervention is the next appropriate step. Definitive surgical candidacy and an operative plan are decided only after an in-person assessment with endoscopy and CT review; remote recommendations cannot replace this evaluation.","Urgent evaluation is required for red-flag signs that suggest orbital or intracranial extension. These include acute visual changes, marked periorbital swelling, new ophthalmoplegia (eye-movement weakness), severe unilateral facial pain, high persistent fever, neck stiffness, altered mental status, or focal neurologic deficits. Any of these symptoms should prompt immediate emergency care or expedited clinic contact for urgent imaging and specialist coordination. Early recognition and rapid imaging-directed management reduce the risk of permanent vision or neurologic injury.","Consider referral for surgical consultation when symptoms recur frequently or when multiple antibiotic or steroid courses are required within a single year. Symptom burden and failure of topical therapies due to anatomic obstruction often predict benefit from procedural correction even when CT abnormalities appear modest. Revision cases—patients whose symptoms return after prior surgery—require a reconstructive-minded approach because scar tissue and altered anatomy change operative strategy. In all such cases, bring prior operative notes and imaging to the consultation to allow accurate comparison and planning.","If you experience worsening olfaction, new sleep-disordered breathing symptoms, or decline in asthma control despite sinonasal therapy, coordinate multidisciplinary care. Allergy and pulmonology collaboration can clarify triggers and modify systemic management. For patients being considered for biologic therapy, joint evaluation with allergy or immunology helps determine candidacy and sequencing relative to surgery. National guidance such as EPOS 2020 and AAO‑HNS documents provide frameworks for timing of referral and escalation; links to those resources are provided below for further reading."]},{"heading":"Related procedures and conditions","paragraphs":["Endoscopic sinus surgery often intersects with other targeted nasal procedures. When disease involves multiple sinuses or when ostial opening and mucosal preservation are required, consider endoscopic sinus surgery (FESS) in NYC — /sinus-infections-sinus-surgery/ — to restore drainage pathways. FESS is frequently paired with septoplasty or turbinate procedures to optimize airway dynamics and improve topical medication delivery. Reviewing the FESS page helps patients understand anatomic targets and how combined procedures create a durable platform for postoperative topical therapy.","Balloon sinuplasty offers a less t

1issue-disruptive alternative when single-ostium disease predominates. For well-selected anatomy, balloon sinuplasty in NYC — /balloon-sinuplasty-nyc/ — can dilate sinus openings with limited mucosal resection. The technique is constrained by disease extent; diffuse polyposis or extensive mucosal disease usually requires tissue-directed FESS. Comparative evidence, including systematic reviews, guides selection between dilation and conventional surgery and is provided in the references below to support individualized decision-making.","Structural contributors such as a deviated septum or turbinate hypertrophy frequently determine symptom persistence and topical delivery failure. Septoplasty surgery for a deviated septum — /septoplasty-surgery-nyc/ — corrects a mechanical nasal barrier, while turbinate reduction to improve nasal airflow — /turbinate-reduction/ — addresses persistent lateral wall or mucosal obstruction. Treating these conditions during the same operative session reduces the chance of continued lateralized airflow and improves access for postoperative rinses and steroid delivery, supporting longer-term control of sinonasal inflammation.","Inflammatory conditions such as nasal polyps and chronic rhinitis modify both operative strategy and postoperative care. Surgical treatment of nasal polyps — /nasal-polyps-surgery/ — may involve targeted polypectomy alongside FESS to reestablish ostial patency. When eosinophilic inflammation predominates, medical options including biologic therapy are part of the multidisciplinary discussion. Linking these condition pages clarifies how anatomy and inflammation interact and why coordinated medical and surgical planning often produces the most durable symptom control."]},{"heading":"Next steps and consultation","paragraphs":["A focused consultation in Manhattan begins with a detailed symptom history, records review, and office nasal endoscopy (a brief, in-office camera exam). Bring prior sinus CT images and radiology reports, operative notes from any prior nasal surgery, recent allergy testing results, and a complete medication list that includes systemic steroid courses and any biologic agents. If possible, upload DICOM CT files before the visit; this allows Dr. Moustafa Mourad to review anatomy in advance and use the appointment time for shared decision-making rather than record collection. Surgical decisions follow only after this in-person evaluation.","Week-by-week recovery roadmap — Days 0–7: Expect nasal congestion, moderate mucous drainage, and mild facial pressure. Pain is usually controlled with oral analgesics. Saline irrigations begin on postoperative day one unless instructed otherwise. Clinic contact within the first week addresses bleeding or severe pain. Early red flags include brisk bleeding that does not slow with simple measures, new vision change, vomiting with severe headache, or fever above 101°F (38.3°C); these require immediate evaluation. Routine debridement may be performed at the first clinic visit depending on intraoperative findings.","Week-by-week recovery roadmap — Weeks 1–3: Nasal crusting and bloody drainage gradually diminish. Clinic debridement or cleaning of crusts commonly occurs at one to two-week intervals until mucosa heals. Continue daily saline irrigations and begin topical steroid irrigations or sprays as instructed, typically after the first office debridement. Return-to-work timelines vary by role; desk work is often possible within one week, while heavy lifting and contact sports should be avoided for three to four weeks. Persistent severe pain, worsening drainage, or new neurological symptoms at any time warrant urgent review.","Week-by-week recovery roadmap — Weeks 4–6 and Months 2–3: By weeks four to six, swelling reduces and breathing usually improves. Smell may begin to recover, particularly when polyp burden was reduced, but olfactory improvement is often gradual over months. Clinic visits continue at staged intervals for debridement and endoscopic assessment; adherence to topical therapy supports mucosal remodeling. By months two to three many patients resume full activities with clearance from the surgeon, though some residual crusting or intermittent congestion can persist. Long-term topical maintenance often remains 

1necessary to sustain benefit.","Long-term expectations and warning signs — 6+ months: By six months mucosa typically matures and the majority of procedural benefit is evident, though allergic or eosinophilic drivers may cause recurrence over longer intervals. Revision rates depend on inflammatory phenotype and initial disease severity; patients with severe eosinophilic polyposis may require ongoing medical therapy or staged interventions. Warning signs at any stage include new visual disturbance, increased facial swelling, persistent fever, or sudden neurologic change; these require immediate assessment. If symptoms recur after an initial period of improvement, schedule re-evaluation with endoscopy and CT comparison before assuming medical therapy alone."]}]'),m=[{q:"How is chronic rhinosinusitis definitively diagnosed in the office?",a:"Diagnosis requires a compatible history of sinonasal symptoms for at least 12 weeks plus objective findings on nasal endoscopy or sinus CT. In clinic Dr. Mourad performs flexible or rigid nasal endoscopy to document polyps, mucopus, edema, or ostial obstruction. A dedicated sinus CT is reviewed with the patient to map involved sinuses and anatomical contributors. Diagnosis and the subsequent plan integrate symptom pattern, endoscopic findings, and imaging together."},{q:"Which symptoms suggest chronic sinusitis rather than allergies or migraine?",a:"Persistent nasal congestion, purulent rhinorrhea, facial pressure worse with bending, and reduced sense of smell that lasts for months favor chronic rhinosinusitis. Allergic rhinitis often produces sneezing, clear rhinorrhea, and seasonal or trigger-linked patterns. Headache alone without nasal signs or objective endoscopic/CT abnormalities suggests an alternate diagnosis such as migraine. Objective testing helps separate overlapping conditions."},{q:"What objective tests confirm the diagnosis and guide treatment?",a:"Focused nasal endoscopy and a low‑dose sinus CT are the core tests used to confirm disease distribution and anatomy. Endoscopy shows mucosal inflammation, polyps, or purulence that can be sampled for culture when infection is suspected. CT characterizes ostial narrowing, anatomical variants, and the extent of air‑cell opacification. Allergy testing, nasal cytology, or sputum assessment are added when systemic inflammation or asthma is suspected."},{q:"When is surgery indicated instead of continued medical therapy?",a:"Surgery is considered when optimized medical therapy—consistent intranasal steroids, appropriate saline irrigations, and targeted antibiotic or short systemic steroid courses—fails to yield durable improvement. Structural obstruction that prevents topical therapy from reaching diseased mucosa (eg, obstructed ostia, severe septal deviation, or lateralized middle turbinate) also indicates surgery may be beneficial. Progressive polyp burden, recurrent infections, or impaired olfaction despite optimized care prompt surgical consideration. Final candidacy requires in‑person endoscopy and CT review."},{q:"Who is NOT a candidate: absolute and relative contraindications?",a:"Absolute contraindications include inability to tolerate anesthesia or active, uncontrolled systemic illness that makes surgery unsafe. Relative contraindications include pregnancy timing considerations (elective sinus surgery is generally deferred), uncontrolled cardiac or pulmonary disease, or active uncontrolled sinonasal infection that should be treated medically first. Patients unable to adhere to postoperative care, irrigation, and clinic follow‑ups are less likely to benefit from operative treatment. Complex systemic disorders such as cystic fibrosis or primary ciliary dyskinesia often require multidisciplinary medical-first strategies and specialist referral rather than routine endoscopic surgery."},{q:"How do you choose between FESS and balloon sinuplasty?",a:"The decision rests on disease pattern, mucosal health, and anatomic targets on CT and endoscopy. Functional endoscopic sinus surgery (FESS) is chosen when direct mucosal work, polyp removal, or wide drainage openings are needed. Balloon sinuplasty can be appropriate for isolated ostial dilation when mucosa appears healthy and polyps are absent. The operative plan is individualized to restore drainage, preserve mucosa where possible, and optimize long‑term topical therapy delivery."},{q:"What should I expect during recovery after sinus surgery week by week?",a:"Days 0–7: expect nasal packing or absorbable dressings in select cases, moderate congestion, watery drainage, and facial pressure; saline rinses begin when advised and pain is usually controlled with oral medication. Weeks 1–3: scheduled postoperative debridements (typically one to two visits) clear crusts and promote healing; topical steroid sprays or irrigations are started or intensified. Weeks 4–6: swelling and crusting decrease; many patients return to nonstrenuous work and see progressive breathing improvement. Months 2–3: mucosal healing continues, topical therapy is optimized, and smell may gradually recover for some patients. 6+ months: final symptom plateau for many, though polyp recurrence or persistent inflammatory disease may require ongoing medical management. Contact the clinic earlier for fever, heavy bleeding, sudden vision changes, severe worsening pain, or persistent clear nasal leak suggestive of CSF."},{q:"Will surgery improve my sense of smell and nasal breathing?",a:"Surgery often restores airflow and improves topical drug delivery, which may lead to better nasal breathing within days to weeks as swelling resolves. Olfactory recovery is variable: some patients notice improvement within weeks, while others—especially those with long‑standing inflammatory olfactory loss—may take months or have incomplete recovery. Outcomes depend on the underlying cause of smell loss, polyp burden, and degree of mucosal inflammation. Dr. Mourad will set expectations based on your individual exam and imaging."},{q:"Are biologic medications an alternative to surgery for some patients?",a:"Biologics can be an important option for patients with severe eosinophilic chronic rhinosinusitis with nasal polyps or those with comorbid asthma 

1not controlled by conventional therapy. These agents target specific inflammatory pathways and are used in coordination with allergy/pulmonary specialists when criteria are met. Biologics are often adjunctive to surgery rather than universally replacing it; they can reduce polyp size and steroid dependence in selected patients. Treatment choice follows multidisciplinary evaluation and guideline‑based indications."},{q:"What should I bring and how can I prepare for my consultation?",a:"Bring any prior sinus CT scans (DICOM or report), prior endoscopy notes, operative reports, and a list of current medications including nasal sprays and recent antibiotics or systemic steroids. Prepare a concise symptom timeline noting triggers, seasonality, and prior treatment responses. If you have allergy testing, pulmonary records, or recent imaging from other centers, upload or bring them to the visit to allow efficient, anatomy‑driven planning. Definitive treatment recommendations follow the in‑person exam and imaging review."},{q:"How are complex or revision sinus cases evaluated differently?",a:"Revision cases require review of prior operative reports, prior imaging, and careful endoscopic assessment to identify altered anatomy, scar tissue, and residual disease. Planning often uses higher‑resolution CT and sometimes intraoperative navigation; preservation strategies and reconstructive considerations are emphasized when landmarks are distorted. Revision surgery carries different risks and may require staged procedures or combined approaches. Multidisciplinary input is frequently helpful for managing persistent inflammatory drivers."}],h=[{anchor:"endoscopic sinus surgery (FESS) in NYC",target:"/sinus-infections-sinus-surgery/",reason:"Details on FESS technique, indications, and postoperative care relevant to chronic rhinosinusitis."},{anchor:"balloon sinuplasty in NYC",target:"/balloon-sinuplasty-nyc/",reason:"Explains patient selection and expected outcomes for ostial dilation procedures."},{anchor:"septoplasty surgery for a deviated septum",target:"/septoplasty-surgery-nyc/",reason:"Septal correction often accompanies sinus surgery to address anatomic contributors to obstruction."},{anchor:"turbinate reduction to improve nasal airflow",target:"/turbinate-reduction/",reason:"Turbinate procedures are commonly combined with sinus surgery to optimize airflow and topical therapy delivery."},{anchor:"surgical treatment of nasal polyps",target:"/nasal-polyps-surgery/",reason:"Polyp management alters intraoperative strategy and postoperative medical regimens."},{anchor:"chronic rhinitis",target:"/chronic-rhinitis/",reason:"Differentiating rhinitis from sinus disease is a common diagnostic step that influences medical planning."},{anchor:"nasal-valve-collapse-treatment",target:"/nasal-valve-collapse-treatment/",reason:"Nasal valve pathology may coexist with sinus disease and addressing it can improve breathing outcomes."}],y=[{anchor:"EPOS 2020 European position paper on rhinosinusitis and nasal polyps",url:"https://www.european-rhinologic.org/epos-2020",reason:"Comprehensive guideline summarizing diagnosis, medical therapy, and indications for surgery in chronic rhinosinusitis."},{anchor:"AAO‑HNS clinical resources on sinusitis",url:"https://www.entnet.org/",reason:"Authoritative professional guidance on sinusitis evaluation and perioperative considerations from an otolaryngology society."},{anchor:"MedlinePlus: chronic sinusitis overview",url:"https://medlineplus.gov/chronicsinusitis.html",reason:"Patient-facing summary of chronic sinusitis symptoms, diagnosis, and treatments from the U.S. National Library of Medicine."},{anchor:"American Board of Facial Plastic and Reconstructive Surgery (ABFPRS)",url:"https://www.abfprs.org/",reason:"Information on board certification in facial plastic and reconstructive surgery and standards relevant to surgeon credentials."}],g=["Annotated axial sinus CT with ostiomeatal complex highlighted and planned surgical targets","Office nasal endoscopy image showing middle meatal polyp and mucosal edema","Overlay of endoscopic photograph and CT slice indicating maxillary ostial obstruction in a Manhattan clinic setting"],f=["WebPage","BreadcrumbList","FAQPage","MedicalCondition","Physician","MedicalBusiness","MedicalProcedure"],v=JSON.parse('[{"@context":"https://schema.org","@type":"WebPage","url":"https://www.nycfacedoc.com/conditions/chronic-sinusitis/","name":"Chronic Rhinosinusitis: Diagnosis and Treatment in Manhattan","description":"An anatomy-first clinical overview of chronic rhinosinusitis with evaluation, medical management, and surgical options tailored to Manhattan patients.","publisher":{"@type":"MedicalBusiness","name":"MouradNYC","url":"https://www.nycfacedoc.com/"},"mainEntity":{"@type":"MedicalCondition","name":"Chronic rhinosinusitis","alternateName":"chronic sinusitis","description":"Persistent inflammation of the nasal cavity and paranasal sinuses lasting 12 weeks or longer, driven by anatomic obstruction, mucosal inflammation, polyps, or immune factors.","possibleTreatment":[{"@type":"MedicalProcedure","name":"Functional endoscopic sinus surgery (FESS)"},{"@type":"MedicalProcedure","name":"Balloon sinuplasty"},{"@type":"MedicalTherapy","name":"Intranasal corticosteroids and saline irrigation"},{"@type":"MedicalTherapy","name":"Biologic therapy for eosinophilic disease (selected cases)"},{"@type":"MedicalTherapy","name":"Culture-directed antibiotics when infection is documented"}]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.nycfacedoc.com/"},{"@type":"ListItem","position":2,"name":"Conditions","item":"https://www.nycfacedoc.com/conditions/"},{"@type":"ListItem","position":3,"name":"Chronic Rhinosinusitis","item":"https://www.nycfacedoc.com/conditions/chronic-sinusitis/"}]},{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"How is chronic rhinosinusitis definitively diagnosed in the office?","acceptedA

1nswer":{"@type":"Answer","text":"Diagnosis requires a compatible history of sinonasal symptoms for at least 12 weeks plus objective findings on nasal endoscopy or sinus CT. In clinic Dr. Mourad performs flexible or rigid nasal endoscopy to document polyps, mucopus, edema, or ostial obstruction. A dedicated sinus CT is reviewed with the patient to map involved sinuses and anatomical contributors. Diagnosis and the subsequent plan integrate symptom pattern, endoscopic findings, and imaging together."}},{"@type":"Question","name":"Which symptoms suggest chronic sinusitis rather than allergies or migraine?","acceptedAnswer":{"@type":"Answer","text":"Persistent nasal congestion, purulent rhinorrhea, facial pressure worse with bending, and reduced sense of smell that lasts for months favor chronic rhinosinusitis. Allergic rhinitis often produces sneezing, clear rhinorrhea, and seasonal or trigger-linked patterns. Headache alone without nasal signs or objective endoscopic/CT abnormalities suggests an alternate diagnosis such as migraine. Objective testing helps separate overlapping conditions."}},{"@type":"Question","name":"What objective tests confirm the diagnosis and guide treatment?","acceptedA

1nswer":{"@type":"Answer","text":"Focused nasal endoscopy and a low‑dose sinus CT are the core tests used to confirm disease distribution and anatomy. Endoscopy shows mucosal inflammation, polyps, or purulence that can be sampled for culture when infection is suspected. CT characterizes ostial narrowing, anatomical variants, and the extent of air‑cell opacification. Allergy testing, nasal cytology, or sputum assessment are added when systemic inflammation or asthma is suspected."}},{"@type":"Question","name":"When is surgery indicated instead of continued medical therapy?","acceptedAnswer":{"@type":"Answer","text":"Surgery is considered when optimized medical therapy—consistent intranasal steroids, appropriate saline irrigations, and targeted antibiotic or short systemic steroid courses—fails to yield durable improvement. Structural obstruction that prevents topical therapy from reaching diseased mucosa (eg, obstructed ostia, severe septal deviation, or lateralized middle turbinate) also indicates surgery may be beneficial. Progressive polyp burden, recurrent infections, or impaired olfaction despite optimized care prompt surgical consideration. Final candidacy requires in‑person endoscopy and CT review."}},{"@type":"Question","name":"Who is NOT a candidate: absolute and relative contraindications?","acceptedA

1nswer":{"@type":"Answer","text":"Absolute contraindications include inability to tolerate anesthesia or active, uncontrolled systemic illness that makes surgery unsafe. Relative contraindications include pregnancy timing considerations (elective sinus surgery is generally deferred), uncontrolled cardiac or pulmonary disease, or active uncontrolled sinonasal infection that should be treated medically first. Patients unable to adhere to postoperative care, irrigation, and clinic follow‑ups are less likely to benefit from operative treatment. Complex systemic disorders such as cystic fibrosis or primary ciliary dyskinesia often require multidisciplinary medical-first strategies and specialist referral rather than routine endoscopic surgery."}},{"@type":"Question","name":"How do you choose between FESS and balloon sinuplasty?","acceptedAnswer":{"@type":"Answer","text":"The decision rests on disease pattern, mucosal health, and anatomic targets on CT and endoscopy. Functional endoscopic sinus surgery (FESS) is chosen when direct mucosal work, polyp removal, or wide drainage openings are needed. Balloon sinuplasty can be appropriate for isolated ostial dilation when mucosa appears healthy and polyps are absent. The operative plan is individualized to restore drainage, preserve mucosa where possible, and optimize long‑term topical therapy delivery."}},{"@type":"Question","name":"What should I expect during recovery after sinus surgery week by week?","acceptedA

1nswer":{"@type":"Answer","text":"Days 0–7: expect nasal packing or absorbable dressings in select cases, moderate congestion, watery drainage, and facial pressure; saline rinses begin when advised and pain is usually controlled with oral medication. Weeks 1–3: scheduled postoperative debridements (typically one to two visits) clear crusts and promote healing; topical steroid sprays or irrigations are started or intensified. Weeks 4–6: swelling and crusting decrease; many patients return to nonstrenuous work and see progressive breathing improvement. Months 2–3: mucosal healing continues, topical therapy is optimized, and smell may gradually recover for some patients. 6+ months: final symptom plateau for many, though polyp recurrence or persistent inflammatory disease may require ongoing medical management. Contact the clinic earlier for fever, heavy bleeding, sudden vision changes, severe worsening pain, or persistent clear nasal leak suggestive of CSF."}},{"@type":"Question","name":"Will surgery improve my sense of smell and nasal breathing?","acceptedA

1nswer":{"@type":"Answer","text":"Surgery often restores airflow and improves topical drug delivery, which may lead to better nasal breathing within days to weeks as swelling resolves. Olfactory recovery is variable: some patients notice improvement within weeks, while others—especially those with long‑standing inflammatory olfactory loss—may take months or have incomplete recovery. Outcomes depend on the underlying cause of smell loss, polyp burden, and degree of mucosal inflammation. Dr. Mourad will set expectations based on your individual exam and imaging."}},{"@type":"Question","name":"Are biologic medications an alternative to surgery for some patients?","acceptedAnswer":{"@type":"Answer","text":"Biologics can be an important option for patients with severe eosinophilic chronic rhinosinusitis with nasal polyps or those with comorbid asthma not controlled by conventional therapy. These agents target specific inflammatory pathways and are used in coordination with allergy/pulmonary specialists when criteria are met. Biologics are often adjunctive to surgery rather than universally replacing it; they can reduce polyp size and steroid dependence in selected patients. Treatment choice follows multidisciplinary evaluation and guideline‑based indications."}},{"@type":"Question","name":"What should I bring and how can I prepare for my consultation?","acceptedA

1nswer":{"@type":"Answer","text":"Bring any prior sinus CT scans (DICOM or report), prior endoscopy notes, operative reports, and a list of current medications including nasal sprays and recent antibiotics or systemic steroids. Prepare a concise symptom timeline noting triggers, seasonality, and prior treatment responses. If you have allergy testing, pulmonary records, or recent imaging from other centers, upload or bring them to the visit to allow efficient, anatomy‑driven planning. Definitive treatment recommendations follow the in‑person exam and imaging review."}},{"@type":"Question","name":"How are complex or revision sinus cases evaluated differently?","acceptedAnswer":{"@type":"Answer","text":"Revision cases require review of prior operative reports, prior imaging, and careful endoscopic assessment to identify altered anatomy, scar tissue, and residual disease. Planning often uses higher‑resolution CT and sometimes intraoperative navigation; preservation strategies and reconstructive considerations are emphasized when landmarks are distorted. Revision surgery carries different risks and may require staged procedures or combined approaches. Multidisciplinary input is frequently helpful for managing persistent inflammatory drivers."}}]},{"@context":"https://schema.org","@type":"Physician","name":"Moustafa Mourad, MD","medicalSpecialty":["Otolaryngology","Facial Plastic and Reconstructive Surgery"],"description":"Dr. Moustafa Mourad is board-certified by the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology — Head and Neck Surgery and serves as an AAFPRS fellowship director in New York City.","url":"https://www.nycfacedoc.com/"},{"@context":"https://schema.org","@type":"MedicalBusiness","name":"MouradNYC","url":"https://www.nycfacedoc.com/","description":"A Manhattan practice focused on facial plastic and reconstructive care, including evaluation and management of chronic rhinosinusitis."}]'),w={kind:e,slug:i,hero_image:a,source_url:n,title:s,h1:t,meta_description:o,canonical:r,breadcrumb_title:c,og:l,twitter:d,lead:p,sections:u,faqs:m,internal_links:h,external_links:y,image_alt_suggestions:g,schema_types:f,json_ld:v};export{c as breadcrumb_title,r as canonical,w as default,y as external_links,m as faqs,t as h1,a as hero_image,g as image_alt_suggestions,h as internal_links,v as json_ld,e as kind,p as lead,o as meta_description,l as og,f as schema_types,u as sections,i as slug,n as source_url,s as title,d as twitter};